Skip to main content
Erschienen in: Rheumatology International 8/2005

01.10.2005 | Original Article

Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan

verfasst von: Sui-Foon Lo, Chung-Ming Huang, Hsiu-Chen Lin, Chang-Hai Tsai, Fuu-Jen Tsai

Erschienen in: Rheumatology International | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

We investigated whether there is an association between polymorphism of the CYP17 gene and rheumatoid arthritis in Chinese patients in central Taiwan. Genomic DNA was extracted from the peripheral blood of 146 female and 47 male RA patients, as well as from 42 female and 59 male control subjects; restriction fragment length polymorphism (defined as the A1 and A2 alleles) was then determined. Clinical variables such as rheumatoid factor positivity, extra-articular manifestations, and joint erosion were also investigated for the RA patients. We found that more male RA patients had the A1 allele (P=0.019) and fewer female RA patients the A2 allele than control subjects (P=0.048). In male RA patients, A1 carriers showed more extra-articular manifestations (P=0.048). In female patients, a significant decrease in A2 carriers mainly occurred in the later-onset age group (P=0.024). This study suggests that the A2 allele may significantly decrease the overall risk of developing RA. In women, the protective effect of A2 mainly affects the older age group. In men, the clinical severity of RA may decrease in patients with the A2/A2 genotype.
Literatur
1.
Zurück zum Zitat Masi AT (1995) Sex hormones and rheumatoid arthritis: cause and effect relationship in a complex pathophysiology? Clin Exp Rheumatol 13:227–240PubMed Masi AT (1995) Sex hormones and rheumatoid arthritis: cause and effect relationship in a complex pathophysiology? Clin Exp Rheumatol 13:227–240PubMed
2.
Zurück zum Zitat Cutolo M, Accardo S (1991) Sex hormones, HLA and rheumatoid arthritis. Clin Exp Rheumatol 9:641–646PubMed Cutolo M, Accardo S (1991) Sex hormones, HLA and rheumatoid arthritis. Clin Exp Rheumatol 9:641–646PubMed
3.
Zurück zum Zitat Cutolo M, Masi AT (1998) Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypothesis. J Rheumatol 25:1041–1047PubMed Cutolo M, Masi AT (1998) Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypothesis. J Rheumatol 25:1041–1047PubMed
4.
Zurück zum Zitat Cutolo M (1997) Do sex hormones modulate the synovial macrophages in rheumatoid arthritis? Ann Rheum Dis 56:281–286PubMed Cutolo M (1997) Do sex hormones modulate the synovial macrophages in rheumatoid arthritis? Ann Rheum Dis 56:281–286PubMed
5.
Zurück zum Zitat Sthoeger ZM, Chiorazzi N, Lahita RG (1988) Regulation of the immune response by sex steroids. J Immunol 141:91–98PubMed Sthoeger ZM, Chiorazzi N, Lahita RG (1988) Regulation of the immune response by sex steroids. J Immunol 141:91–98PubMed
6.
Zurück zum Zitat Novotny EA, Raveche ES, Sharrow S, Ottinger M, Steinberg AD (1983) Analysis of thymocyte subpopulations following treatment with sex hormones. Clin Immunol Immunopathol 25:205–217CrossRef Novotny EA, Raveche ES, Sharrow S, Ottinger M, Steinberg AD (1983) Analysis of thymocyte subpopulations following treatment with sex hormones. Clin Immunol Immunopathol 25:205–217CrossRef
7.
Zurück zum Zitat Grossman CJ (1985) Interaction between the gonadal steroids and the immune system. Science 227:257–261PubMed Grossman CJ (1985) Interaction between the gonadal steroids and the immune system. Science 227:257–261PubMed
8.
Zurück zum Zitat Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S (1988) Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 31:1314–1317PubMed Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S (1988) Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 31:1314–1317PubMed
9.
Zurück zum Zitat Junghers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF (1982) Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 25:454–457PubMed Junghers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF (1982) Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 25:454–457PubMed
10.
Zurück zum Zitat Lahita RG, Bradlow HL, Kunkel HG, Fishman J (1981) Increased 16-alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 53:174–178PubMed Lahita RG, Bradlow HL, Kunkel HG, Fishman J (1981) Increased 16-alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 53:174–178PubMed
11.
Zurück zum Zitat Masi AT, Josipovic DB, Jefferson WE (1984) Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic (GLC) studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 14:1–23CrossRefPubMed Masi AT, Josipovic DB, Jefferson WE (1984) Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic (GLC) studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 14:1–23CrossRefPubMed
12.
Zurück zum Zitat Lahita RG, Kunkel HG, Bradlow HL (1983) Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 26:1517–1521PubMed Lahita RG, Kunkel HG, Bradlow HL (1983) Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 26:1517–1521PubMed
13.
Zurück zum Zitat Brentano ST, Picardo-Leonard J, Mellon SH, Moore CCD, Miller WL (1990) Tissue-specific, cyclic adenosine 3’, 5’-monophosphate-induced and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 4:1972–1979PubMed Brentano ST, Picardo-Leonard J, Mellon SH, Moore CCD, Miller WL (1990) Tissue-specific, cyclic adenosine 3’, 5’-monophosphate-induced and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 4:1972–1979PubMed
14.
Zurück zum Zitat Cutolo M, Villaggio B, Sulli A, Seriolo B, Giusti M (2000) CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis. Clin Exp Rheumatol 18:420–421PubMed Cutolo M, Villaggio B, Sulli A, Seriolo B, Giusti M (2000) CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis. Clin Exp Rheumatol 18:420–421PubMed
15.
Zurück zum Zitat Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17, 20 lyase): similarity with the gene for P450c21. DNA 6:439–448PubMed Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17, 20 lyase): similarity with the gene for P450c21. DNA 6:439–448PubMed
16.
Zurück zum Zitat Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Frank S, Williamson R (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876PubMed Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Frank S, Williamson R (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876PubMed
17.
Zurück zum Zitat Feigelson HS, Coetzee, GA, Kolone LN, Ross RK, Henderson BE (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063–1065PubMed Feigelson HS, Coetzee, GA, Kolone LN, Ross RK, Henderson BE (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063–1065PubMed
18.
Zurück zum Zitat Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S (1999) Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 84:350–353CrossRefPubMed Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S (1999) Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 84:350–353CrossRefPubMed
19.
Zurück zum Zitat Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB, Hooper ML, Wyllie AH, Steel CM (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141–143CrossRefPubMed Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB, Hooper ML, Wyllie AH, Steel CM (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141–143CrossRefPubMed
20.
Zurück zum Zitat Diamanti-Kandarakis E, Bartzis MI, Zapanti ED, Spina GG, Filandra FA, Tsianateli TC, Bergiele AT, Kouli CR (1999) Polymorphism T–>C (–34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril 71:431–435CrossRefPubMed Diamanti-Kandarakis E, Bartzis MI, Zapanti ED, Spina GG, Filandra FA, Tsianateli TC, Bergiele AT, Kouli CR (1999) Polymorphism T–>C (–34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril 71:431–435CrossRefPubMed
21.
Zurück zum Zitat Lunn RM, Bell DA, Mohler JL, Taylor JA (1999) Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2) Carcinogenesis (Oxford) 20:1727–1731 Lunn RM, Bell DA, Mohler JL, Taylor JA (1999) Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2) Carcinogenesis (Oxford) 20:1727–1731
22.
Zurück zum Zitat Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche MA (2000) Polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 87:434–437CrossRefPubMed Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche MA (2000) Polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 87:434–437CrossRefPubMed
23.
Zurück zum Zitat Huang J, Ushiyama T, Inoue K, Mori K, Hukuda S (1999) Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis. Clin Exp Rheumatol 17:721–724PubMed Huang J, Ushiyama T, Inoue K, Mori K, Hukuda S (1999) Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis. Clin Exp Rheumatol 17:721–724PubMed
24.
Zurück zum Zitat Sullivan KE, Mannery T, Petri MA (1998) The polymorphic CYP17 allele is not found with increased frequency in systemic lupus erythematosus. Arthritis Rheum 41:940–941CrossRefPubMed Sullivan KE, Mannery T, Petri MA (1998) The polymorphic CYP17 allele is not found with increased frequency in systemic lupus erythematosus. Arthritis Rheum 41:940–941CrossRefPubMed
25.
Zurück zum Zitat Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW (1995) HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 22:1450–1454PubMed Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW (1995) HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 22:1450–1454PubMed
26.
Zurück zum Zitat Wadelius M, Andersson AO, Johansson JE, Wadelius C, Rane E (1999) Prostate cancer associated with CYP17genotype. Pharmacogenetics 9:635–639PubMed Wadelius M, Andersson AO, Johansson JE, Wadelius C, Rane E (1999) Prostate cancer associated with CYP17genotype. Pharmacogenetics 9:635–639PubMed
27.
Zurück zum Zitat Habuchi T, Liging Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, Kamoto T, Ogawa O, Kato T (2000) Increased risk of prostate cancer and benign prostatic hyperplasia associated with CYP17 gene polymorphism with a gene dosage effect. Cancer Res 60:5710–5713PubMed Habuchi T, Liging Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, Kamoto T, Ogawa O, Kato T (2000) Increased risk of prostate cancer and benign prostatic hyperplasia associated with CYP17 gene polymorphism with a gene dosage effect. Cancer Res 60:5710–5713PubMed
28.
Zurück zum Zitat Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13:217–226PubMed Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13:217–226PubMed
29.
Zurück zum Zitat Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ (1999) The relationship between polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 59:1015–1020PubMed Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ (1999) The relationship between polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 59:1015–1020PubMed
Metadaten
Titel
Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan
verfasst von
Sui-Foon Lo
Chung-Ming Huang
Hsiu-Chen Lin
Chang-Hai Tsai
Fuu-Jen Tsai
Publikationsdatum
01.10.2005
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 8/2005
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0479-4

Weitere Artikel der Ausgabe 8/2005

Rheumatology International 8/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.